Showing results (1-10 of 4) with videos related to
Sort By:
Pageof 1
Diagnostic Cytopathology|January 23, 2016
HER 2 immunohistochemistry for breast cancer cell blocks can be used in the same way as that used for histological specimensRieko Nishimura, Nami Okamoto, Masakazu Satou, et al.Breast Cancer (Tokyo, Japan)|January 10, 2016
Bright-field HER2 dual in situ hybridization (DISH) assay on breast cancer cell blocks: a comparative study with histological sectionsRieko Nishimura, Nami Okamoto, Masakazu Satou, et al.Breast Cancer (Tokyo, Japan)|July 19, 2014
Correlation of HER2 gene status assessment by fluorescence in situ hybridization between histological sections and cytological specimens of breast cancerRieko Nishimura, Akihiro Kagawa, Sachiko Tamogami, et al.Biochemical and Biophysical Research Communications|February 17, 2022
TTR exon-humanized mouse optimal for verifying new therapies for FAPZhenghua Li, Hideki Kanazashi, Yoshimi Tokashiki, et al.Pageof 1